CA
NZ
UK
AU
IND
US
TELA Bio, Inc. (NASDAQ: TELA) is asking shareholders to approve aReverse Stock Splitat a special meeting on October 8, 2026. The proposal would combine outstanding common stock at a ratio ranging from one-for-five to one-for-fifteen. A second measure would allow the meeting to be …
SONOCO PRODUCTS CO. (NYSE: SON) awarded Harrell James A. III 264 derivative securities at $48.43 per share on September 10, 2026. The transaction involved the executive identified as president of Global Ind. Paper Pkg.
SONOCO PRODUCTS CO (NYSE: SON) awarded Chief Operating Officer Fuller Rodger D 48 derivative securities at $48.43 per share on Sep. 10, 2026.
Sonoco Products Co. (NYSE: SON) awarded director Pamela Lewis 777 derivative securities at $48.43 per share on September 10, 2026.
SONOCO PRODUCTS CO. (NYSE: SON) awarded director Philippe Guillemot 331 derivative securities at $48.43 per share on Sep. 10, 2026. The transaction left Guillemot with 29,981 derivative securities, while the award represented about 1.1% of that resulting holding.
SONOCO PRODUCTS CO. (NYSE: SON) awarded Drew Theresa J 248 derivative securities on September 10, 2026. The transaction involved a director of the company.
SONOCO PRODUCTS CO (NYSE: SON) awarded 824 derivative securities to President and CEO Coker R. Howard at $48.43 per share on September 10, 2026. Following the transaction, Howard owned 20,531 derivative securities of SONOCO PRODUCTS CO. It was recorded under transaction code A.
SONOCO PRODUCTS CO. (NYSE: SON) awarded executive Sean Cairns 75 derivative securities at $48.43 per share on September 10.
SONOCO PRODUCTS CO (NYSE: SON) awarded director Boyd Steven L 124 derivative securities at $48.43 per share on Sep 10.
SOPHiA GENETICS SA (NASDAQ: SOPH) Chief Legal Officer Van Well Daan sold 6,168 shares at $7.63 per share. The transaction took place on 11 September 2026.
Please wait processing your request...